Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
One in seven (14%) employers covering GLP-1s for obesity are considering discontinuation due to cost
Video Endoscopic Sequence 4 of 8
Key Takeaways Fat pad loss: Rapid weight loss from GLP-1 drugs can reduce natural fat pads in feet, causing pain and discomfort Prevention is crucial: Maintaining protein intake and resistance training helps preserve muscle and fat pad integrity Professional care helps: Early podiatric intervention can prevent complications and provide effective pain management Diabetic considerations: Patients with type 2 diabetes face additional risks including foot ulcers and neuropathy Treatment options exist: Custom orthotics, padding, and targeted therapies can restore foot comfort and function Understanding Ozempic Feet: The Medical Reality The term Ozempic feet describes foot-related complications that can occur when someone loses weight rapidly while taking GLP-1 medications such as Ozempic, Wegovy, or other similar drugs
Personal training Lifestyle modifications, including practicing good sleep hygiene and stress management Medications For more information on this topic, please reach out to RescueMD at 972-390-7667
Independent licensed healthcare providers on the Eden platform can help assess your eligibility for currently available treatment options and guide you every step of the way
[1] [5] While there is limited evidence that GLP-1 receptor activation may influence sodium excretion (natriuresis) in experimental settings, this has not translated to clinically significant urinary frequency in clinical trials or post-marketing surveillance
